BUY Niva Bupa Health Insurance Company Limited — Motilal Oswal
byMotilal OswalHorizon: NA (inferred 1 year)31 Jul 2025via Institutional / Brokerage Research
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Niva Bupa Health Insurance reported a 93% year-on-year growth in Profit After Tax (PAT) to ₹138 crore for the quarter ended June 30, 2026. Gross Written Premium (GWP) increased by 32% to ₹2,150 crore.
BSE · Company Update·30 Jul · today
ICRA Limited has assigned an Issuer Rating of '[ICRA]AAA(Stable)' to Niva Bupa Health Insurance Company Ltd. The rating is valid for one year from the date of communication.
BSE · Company Update·15 Jul · 2w ago
Niva Bupa Health Insurance Company Limited has received a refund sanction order of ₹22.12 crores from the Office of the Deputy Commissioner of State Tax, Mumbai. This relates to a pending litigation c
NSE · Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company·15 Jul · 2w ago
1 other SEBI-registered advisor has an active long-term BUY call on this stock
Advisor consensus · same horizon·6 Nov · 9mo ago
Outcome of Board meeting held on July 30, 2026- Unaudited financial results for quarter ended June, 2026 and raising of funds by way of issuance of Debentures
BSE · Board Meeting·30 Jul · today
Niva Bupa Health Insurance Company Ltd will hold a board meeting on July 30, 2026, to approve unaudited financial results for Q1 FY27 and consider a proposal for fundraising via Non-Convertible Debent
BSE · Board Meeting·23 Jul · 1w ago
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Niva Bupa Health Insurance Company
- SELL — Nagaraj Shetty, HDFC Securities29 Sept 2026 · ~3 months · target ₹70 · Active
- BUY — IDBI Capital21 Sept 2026 · ~2 weeks · target ₹85.3 · SL hit
- BUY — Osho Krishan, Angel One30 Jul 2026 · ~2 weeks · target ₹92 · Expired
- BUY — Motilal Oswal30 Jul 2026 · ~1 year · target ₹103 · Active
- BUY — Motilal Oswal19 Jun 2026 · ~1 year · target ₹100 · Active
More from Motilal Oswal
- BUY Colgate Palmolive (India)22 Oct 2026 · ~1 year · target ₹2,000 · Active
- BUY Sapphire Foods India22 Oct 2026 · ~1 year · target ₹245 · Active
- BUY CIE Automotive India22 Oct 2026 · ~1 year · target ₹440 · Active
- BUY CREDITACCESS GRAMEEN22 Oct 2026 · ~1 year · target ₹1,450 · Active
- BUY KEI Industries22 Oct 2026 · ~1 year · target ₹5,180 · Active

